GlassScriptPhysician profile
Mohammad Zmaili
NPI 1306334768
$3,219.89
in general payments reported to CMS, 2019-2025
10 companies · $2,451 in 2025
The $2,451 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $276 · 2024: $492 · 2025: $2,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,270 · Travel and Lodging: $768 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,269.79 |
| Travel and Lodging | $768.21 |
| Education | $181.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,460.20 | 2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| Abbott Laboratories | $411.37 | 2024-2025 | Esprit, Optis, Pressurewire |
| Medtronic, INC. | $298.71 | 2024-2025 | Resolute Onyx |
| Cardiovascular Systems INC. | $276.12 | 2023 | Diamondback Coronary |
| Boston Scientific Corporation | $180.22 | 2024-2025 | Eluvia |
| Teleflex LLC | $150.29 | 2025 | Trapliner |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Abiomed | $137.89 | 2025 | |
| Stryker Corporation | $124.09 | 2025 | Flowtriever |
| Shockwave Medical, INC | $39.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Zmaili listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.